- Home
- STRO vs SNFCA Comparison
STRO vs SNFCA Comparison
Compare STRO & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- SNFCA
- Stock Information
- Founded
- STRO 2003
- SNFCA 1965
- Country
- STRO United States
- SNFCA United States
- Employees
- STRO N/A
- SNFCA N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- SNFCA Finance: Consumer Services
- Sector
- STRO Health Care
- SNFCA Finance
- Exchange
- STRO Nasdaq
- SNFCA Nasdaq
- Market Cap
- STRO 172.8M
- SNFCA 285.8M
- IPO Year
- STRO 2018
- SNFCA N/A
- Fundamental
- Price
- STRO $1.97
- SNFCA $11.93
- Analyst Decision
- STRO Strong Buy
- SNFCA
- Analyst Count
- STRO 7
- SNFCA 0
- Target Price
- STRO $12.14
- SNFCA N/A
- AVG Volume (30 Days)
- STRO 1.4M
- SNFCA 39.7K
- Earning Date
- STRO 11-13-2024
- SNFCA 11-14-2024
- Dividend Yield
- STRO N/A
- SNFCA N/A
- EPS Growth
- STRO N/A
- SNFCA N/A
- EPS
- STRO N/A
- SNFCA 1.23
- Revenue
- STRO $160,955,000.00
- SNFCA $330,162,091.00
- Revenue This Year
- STRO N/A
- SNFCA N/A
- Revenue Next Year
- STRO N/A
- SNFCA N/A
- P/E Ratio
- STRO N/A
- SNFCA $9.62
- Revenue Growth
- STRO 230.90
- SNFCA N/A
- 52 Week Low
- STRO $1.70
- SNFCA $6.19
- 52 Week High
- STRO $6.13
- SNFCA $13.59
- Technical
- Relative Strength Index (RSI)
- STRO 31.89
- SNFCA 39.18
- Support Level
- STRO $1.70
- SNFCA $11.62
- Resistance Level
- STRO $3.01
- SNFCA $11.96
- Average True Range (ATR)
- STRO 0.20
- SNFCA 0.38
- MACD
- STRO -0.01
- SNFCA -0.25
- Stochastic Oscillator
- STRO 20.61
- SNFCA 5.69
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About SNFCA Security National Financial Corporation
Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.